Related by context. All words. (Click for frequent words.) 66 FDA approvable letter 65 BLA submission 65 Complete Response Letter 65 IND Investigational New 65 Biologics License Application BLA 64 BLA filing 64 testosterone gel LibiGel 64 Marketing Authorisation Application 63 Orathecin 62 T Pred 62 FDA Approvable Letter 62 lorcaserin NDA 62 LibiGel NDA 62 Marketing Authorization Application MAA 62 MAA submission 62 Intermezzo ® NDA 62 FDA Complete Response 62 Marketing Authorization Application 62 Approvable letter 61 Complete Response letter 61 NDA resubmission 61 Marketing Authorisation Application MAA 61 IND submission 61 ZEGERID Chewable Tablets 61 ZEGERID Capsules 61 REMOXY NDA 61 Biologics License Application 60 Complete Response 60 granted Ortec 60 Contrave NDA 60 Biologic License Application 60 Biological License Application 60 KRYSTEXXA TM pegloticase 60 supplemental biologics 59 PDUFA Date 59 sBLA 59 PMA submission 59 SURFAXIN 59 NYSE Amex PTN 59 Exelbine NDA 59 M Enoxaparin 59 supplemental Biologics License Application 59 mesylate tablets 59 Nasdaq CYCC Nasdaq CYCCP 59 blood thinner prasugrel 59 Resubmission 59 Acetavance TM 59 Approvable Letter 58 Audited Financials 58 NDA submission 58 DPX Survivac 58 Application BLA 58 PROVENGE sipuleucel T 58 Files Investigational 58 Rhucin R 58 Exelbine 58 application sNDA 58 Act PDUFA date 58 commercialize oritavancin 58 Biologic License Application BLA 58 Application MAA 58 PDUFA date 58 Premarket Approval Application 58 CRMD# 58 BioDelivery Sciences 58 approvable letters 58 StaphVAX R 58 BRILINTA 58 Barr ANDA 58 markets HP Acthar 58 SinuNase ™ 58 Marketing Approval PMA 58 severe hypercholesterolemia 58 Nasdaq IDRA 58 autologous cellular immunotherapy 57 DATES Comments 57 assigned PDUFA 57 liver resection surgeries 57 alogliptin NDA 57 balsalazide tablet 57 SWX BSLN 57 NASDAQ APPA specialty 57 Hematide ™ peginesatide 57 Sertraline Hydrochloride Tablets 57 KRYSTEXXA TM 57 candidate REP# 57 initiate Phase IIb 57 Marketing Authorization Applications 57 NDA Submission 57 PROGENSA R 57 Premarket Approval PMA 57 resubmission 57 SWX SPPN 57 AAG geldanamycin analog 57 Announces Tentative Approval 57 Complete Response Letter CRL 57 NASDAQ CXSP announced 57 APF# 57 NASDAQ BDSI 57 pixantrone NDA 57 CERVARIX R 57 Onyx Pharma 56 sNDA 56 FACTIVE R gemifloxacin 56 Corlux 56 Pirfenidone 56 ENRICH trial 56 Risperidone Oral Solution 56 Sular formulation 56 IND CTA 56 midstage studies 56 Voraxaze 56 Drug Submission 56 FOLOTYN ® 56 OTC BB PVCT 56 sNDA submission 56 Palatin Technologies Inc. 56 AVANIR Pharmaceuticals Inc. 56 Nasdaq OSCI 56 CLIRS trial 56 Ltd Therapeutic Competitors 56 NASDAQ SOMX specialty 56 Biologics License Applications 56 Auxilium Pharma 56 SPL# Gel vaginal microbicide 56 Market Authorization Application 56 Romiplostim 56 CIP TRAMADOL ER 56 Teikoku Pharma USA 56 New Drug Application 56 Nasdaq HALO 56 Emezine 56 GRAS notification 56 OMAPRO ™ 56 LO LOESTRIN FE 56 NASDAQ FLML 56 SPARLON 56 Paragraph IV 56 RIGScan CR 56 Zensana 56 USFDA approval 56 Nasdaq NPSP announced 56 ANDA containing 56 JZP 56 Rhucin 56 sBLA filings 56 Initiates Enrollment 56 Zingo TM 56 Summary Genmab 55 Nabi HB Intravenous 55 generic Lovenox 55 AMEX ONI 55 zileuton CR 55 NSE SUNPHARMA 55 Glybera R 55 Flutiform ™ 55 OFIRMEV 55 PANVAC VF 55 PRAECIS PHARMACEUTICALS INCORPORATED 55 VitiGam 55 NASDAQ IPXL today 55 Fx #A 55 Dru Polk 55 Hedgehog Pathway Inhibitor 55 generic Copaxone 55 Inc. Nasdaq ALTH 55 IND Filing 55 Receives Tentative FDA 55 NasdaqGM NTEC today 55 highly purified pasteurized 55 oral ridaforolimus 55 GATTEX TM 55 NASDAQ ALTH 55 TRANSDUR ® 55 Civacir 55 Silenor NDA 55 Fodosine 55 Phase 1b Clinical Trial 55 midstage trials 55 Biomerix Corporation 55 Market Approval PMA 55 Stavzor 55 Aloxi Injection 55 DATES Written comments 55 Omapro 55 Arno Therapeutics 55 rhThrombin 55 NASDAQ CLSN 55 Submits Response 55 ZEGERID Powder 55 Dacogen injection 54 Viviant 54 PLK1 SNALP 54 Febuxostat 54 Omigard 54 FDA Accepts 54 novel trazodone formulation 54 peginesatide 54 IMA# 54 IND enabling 54 Nasdaq SKYE 54 Omnitrope 54 MKC# MKC# PP 54 PROSTASCINT R 54 oxymorphone ER 54 alogliptin 54 VALSTAR 54 GLP toxicology studies 54 Completes Patient Enrollment 54 Zenpep 54 phase IIb trial 54 Dated announcements 54 ASX PGL 54 Thelin TM 54 SCHWARZ PHARMA 54 elotuzumab 54 Oracea TM 54 Master File DMF 54 Novartis VIRT X 54 serine protease inhibitor CU# 54 NASDAQ ABPI 54 Allovectin 7 r 54 trastuzumab DM1 T DM1 54 Pre IND 54 eCTD format 54 Acetavance 54 NYSE Amex HEB 54 postapproval 54 Submits Biologics License Application 54 NASDAQ TARG 54 Evoltra TM 54 PREOS R 54 proprietary Capillary Aerosolization Technology 54 CHMP recommendation 54 virus HCV protease inhibitor 54 Paragraph IV Notice 54 Drug Applications ANDAs 54 Patient Enrollment 54 Saforis 54 Submits Investigational 54 OvaRex ® MAb 54 Nasdaq VRTX 54 SFDA approval 54 ISO Vorin TM 54 Phase IIb trials 54 mesylate tablets approved 54 ZEVALIN ® 54 Amicus Therapeutics Nasdaq FOLD 54 KIACTA ™ 54 Submits NDA 54 Tezampanel 54 TSX SHQ 54 SUCCEED trial 54 Not Approvable 54 pivotal bioequivalence 54 Inc. Nasdaq DSCO 54 attorney WH Newbold 54 Kynapid 54 ALN HPN 54 Regeneron Pharma 54 ONCONASE R 54 Ascent Therapeutics 54 Diep Tran MD 54 4BETTER OR WORSE 54 Clinical Trials Update 54 KYNAPID 54 Ketotransdel 54 generic Valtrex 54 NASDAQ PGNX 54 Phase III Clinical Trials 54 Gentamicin Surgical Implant 54 Zolpidem Tartrate Tablets 54 sitaxsentan sodium 54 TSX VENTURE QRM 54 PDE4 inhibitor 54 non constipation irritable 54 NASDAQ NOVN today 54 telavancin NDA 54 WHO prequalification 54 Dyloject TM 54 Preotact 54 Nicotine Conjugate Vaccine 54 Angiocept 54 Mycograb 54 Preos 54 tiapamil 54 oral methylnaltrexone 53 miconazole MBT 53 Nasdaq VRTX today 53 IIa trial 53 LSE SHP.L 53 Nasdaq RGEN 53 sNDAs 53 nasal calcitonin product 53 Morphine Sulfate 53 OTCBB UGNE http:/www.unigene.com 53 Zenvia ™ 53 Firazyr 53 Adventrx 53 Inc. Nasdaq SUPG 53 Orthopedic Advisory Panel 53 Receives Approvable Letter 53 Pharmos pipeline 53 Entereg alvimopan 53 CDP# 53 AMPAKINE CX# 53 Mylan Receives Approval 53 subsidiaries visit http:/www.apricusbio.com 53 Inc. OTCBB VODG 53 OLpur TM H2H 53 AstraZeneca Symbicort 53 Personalized Immunotherapy 53 Inc. Nasdaq IDIX 53 Onsolis 53 MacroChem Corporation 53 Amlodipine Besylate Tablets 53 Vibativ 53 Corporation Nasdaq GENR 53 Orapred ODT 53 Nasdaq KOSN 53 Therapeutic Competitors Companies 53 dirucotide 53 Antegren 53 Synerx Pharma 53 Paris IPN 53 PREOS 53 severe gastroparesis 53 torezolid phosphate 53 AB OMXS BINV 53 Supplemental Biologics License Application 53 Phase 2a clinical trials 53 Krystexxa 53 Replagal 53 Battle royale Mediate 53 By JAMAAL ABDUL 53 MyVax 53 Nasdaq ANDS 53 FUSILEV ® 53 BioGlue ® 53 Telatinib 53 SILENOR 53 Phase lll 53 JOULFERON 53 Milestone Payment From 53 including eniluracil ADH 53 Bionutrics 53 TAXUS Element Stent System 53 Romidepsin 53 Nasdaq EPCT 53 Anidulafungin 53 Replagal TM 53 Investigational Device Exemption 53 submit Biologics License 53 Topiramate Tablets 53 Release Capsules 53 rolling Biologics License 53 Evoltra R 53 Inc. NASDAQ HITK 53 Nasdaq SVNT 53 Accelerated Approval 53 registrational trial 53 Nasdaq DYAX 53 vinorelbine emulsion 53 orphan designation 53 Cephalon NASDAQ CEPH 53 Linjeta 53 Pixuvri 53 SAR# [004] 53 Panzem 53 Oral Calcitonin 53 ponatinib 53 PRECISE Trial 53 Xinlay 53 Ocrelizumab 53 MyVax R 53 PROMUS Element Stent System 53 MNM Magellan 53 Solzira 53 submitted Biologics License 53 JZP 6 53 Inc. NASDAQ AVNR 53 Holdings Limited LRE 53 GTC recombinant form 53 Centralized Procedure 53 Testosterone MDTS ® 53 NeoMagic circle 53 registrational 53 LSE SKP 53 Kamada AAT 53 Troxatyl TM 53 CAMPATH 53 Exalgo 53 Ceflatonin ® 53 Strativa 53 Panzem R 53 Exherin TM 53 NASDAQ DYAX 53 Vertex Pharma 53 PharmaVitae Profile 53 Evoltra ® 53 platforms GVAX 53 EURONEXT SAN 53 Company NASDAQ MDCO 53 indiplon capsules 53 Speedel Holding Ltd 53 Successfully Completes Phase 53 Arpida 53 Partnering Guide 53 CeNeS Pharmaceuticals plc 53 NASDAQ INGN 53 ANDA filings 53 pralatrexate injection folate analogue 53 oral taxane 53 Inc. Nasdaq SEPR 53 CD# CEA 53 commercialize CorMedix drug 52 product platforms GVAX 52 Alnylam Biotherapeutics 52 Employment Inducement Awards 52 Optimer Pharma 52 OMP designation 52 zanolimumab 52 Company NYSE KVa 52 Cintredekin Besudotox 52 ALN PCS 52 Exocrine Pancreatic Insufficiency 52 Alogliptin 52 StaphVAX 52 Arzerra ofatumumab 52 Somatuline R Autogel R 52 Phase Ib study 52 malignant mesothelioma Alfacell 52 ATPace TM 52 Lumizyme 52 postoperative ileus POI 52 generation URAT1 inhibitor 52 Targanta Therapeutics Corporation 52 HCl Injection 52 Kyron disappearance Kaine Horman 52 Orexigen Contrave 52 Flutiform 52 By Alexander Varty 52 Inc. Nasdaq IMGN 52 KRYSTEXXA ™ 52 publication MadPennyStocks.com 52 INDs 52 LibiGel ® 52 Insmed Incorporated NASDAQ INSM 52 Ventrus 52 Horizant 52 QRxPharma 52 ALVESCO R 52 Inc. Nasdaq VNDA 52 blood thinner rivaroxaban 52 PRNewswire FirstCall Genta Incorporated 52 By RohitSharma TennisEarth.com 52 R sipuleucel T 52 casopitant 52 ANDAs pending FDA 52 developing ostarine selective 52 Milestone Payment 52 plc Nasdaq WCRX 52 alvimopan 52 Amyvid 52 Fast Track designations 52 overactive bladder AA# 52 Submits Supplemental 52 pantoprazole sodium 52 NASDAQ IPXL 52 Theratechnologies submitted 52 Phase IIIb clinical 52 Impax ANDA 52 Controls CMC 52 Pivotal Phase III 52 Ohr Pharmaceutical Inc. 52 ATL/TV# 52 Drug Application 52 Zenvia Phase III 52 PRNewswire FirstCall SkyePharma PLC 52 Dose Ranging Study 52 BLOOM DM 52 ILUVIEN ® 52 Act PDUFA guidelines 52 OTCQX QRXPY 52 balsalazide disodium 52 Ereska 52 Phase IIa trial 52 ZALBIN 52 Alnylam Pharma 52 PNT# 52 OMP #R# 52 Nasdaq DVAX 52 investigational hepatitis B 52 IMPAX Laboratories Inc. 52 phase IIb study 52 Phoqus 52 PNP inhibitor 52 Nasdaq ACHN 52 Junovan TM 52 XL# anticancer compounds 52 CyDex Pharmaceuticals 52 NASDAQ ISPH announced 52 SinuNase TM 52 Rhucin ® 52 therefore therapeutically equivalent 52 Receives Fast Track 52 Nebido 52 CB2 selective receptor agonist 52 Inc. NASDAQ ACUS 52 L DOS# 52 By tech3 52 ATPace 52 Zalbin 52 Sunesis Pharmaceuticals 52 FavId 52 Inc. Amex PTN 52 Linjeta TM 52 nonclinical studies 52 Luveniq 52 intravenous acetaminophen 52 RANK Ligand inhibitor 52 RIGScan ™ 52 Nasdaq PGNX today 52 Lupin Pharmaceuticals Inc. 52 oral proteasome inhibitor 52 successfully commercialize Iluvien 52 Iluvien ® 52 Pharmaxis ASX PXS 52 Xcytrin R 52 Surfaxin lucinactant 52 MAGE A3 ASCI 52 SNT MC# 52 phase IIb 52 Arzerra TM 52 By KATE TAYLOR 52 Citizen Petition 52 Phase Ib II 52 mertansine 52 Nasdaq ADLS 52 Archexin 52 Vilazodone 52 Durata Therapeutics 52 Ofirmev 52 Principle AIP 52 Velaglucerase Alfa 52 Dementia Related Psychosis 52 Fortigel 52 OMAPRO 52 Nasdaq NABI 52 cervical cancer vaccine Cervarix 52 TBC# 52 Hedgehog antagonist 52 Intellipharmaceutics 52 sumatriptan DosePro 52 Phase III Clinical Trial 52 QNEXA 52 NEBIDO 52 Paragraph IV Certification 52 Maxy G# 52 Speedel SWX SPPN 52 Panflu TM Sinovac 52 ELADUR ™ 52 Plicera 52 oral prodrug 52 Nasdaq BDSI 52 Onco TCS 52 PROVENGE ® 52 Transcept Pharmaceuticals 52 Levoleucovorin 52 Alnara 52 ANDA Abbreviated New 52 apricitabine ATC 52 Nasdaq CADX 52 Sumatriptan Succinate Tablets 52 candidate deforolimus 52 publication PennyStockVille.com 52 SPRINGFIELD ENEWSPF 52 Valtropin 52 tramiprosate Alzhemed TM 52 bioequivalency 52 Transkaryotic Therapies TKTX 52 Drug Submission NDS 52 Orazol 52 Inc. NASDAQ NEOL 52 Mylan ANDA 52 Friedreich Ataxia FRDA 52 submitted Marketing Authorization 52 NASDAQ AVEO 52 OMNARIS Nasal Spray 52 CHMP opinion 52 ENZON 52 Mepact 52 vapreotide acetate 52 compound PMX # 52 Dr. Laikind 52 rasagiline tablets 52 acyclovir Lauriad R 52 FLECTOR ® Patch 51 NYSE Amex Listing 51 MAXY alpha 51 Indevus Pharma 51 Augment Bone Graft 51 JunJing III 51 Ista Pharmaceuticals Inc 51 IG HCR ;) CO 51 NASDAQ NPSP 51 Initiate Phase 51 WILEX 51 By Hayley Tsukayama 51 Phase 2a Trial 51 Vertex hepatitis C 51 Nasdaq AVNC 51 Teflaro 51 ZADAXIN ® 51 investigational humanized monoclonal antibody 51 gabapentin tablets 51 NASDAQ SHPGY 51 Inamine celebrated 51 vinorelbine tartrate 51 Nasdaq NBIX 51 Act PDUFA 51 Company Nasdaq PRGO 51 ruxolitinib 51 maribavir 51 Inc. Nasdaq MYL 51 Pivotal Clinical Trial 51 Chemical Entity NCE 51 Prodarsan R 51 Co. Nasdaq PPCO 51 ULTRASE 51 Nasdaq Delisting Notification 51 Ceflatonin 51 Files IND 51 phase IIb clinical 51 Nexavar sorafenib 51 diarrhea predominant irritable 51 Roflumilast 51 CIP ISOTRETINOIN 51 BENLYSTA 51 submitted supplemental Biologics 51 LymphoStat B TM 51 Dendreon Provenge 51 Inc. Amex AIS 51 BLP# Liposome Vaccine 51 Inc. NASDAQ NTMD 51 L MTP PE 51 XOMA 3AB 51 Troxatyl 51 pralatrexate 51 BrachySil 51 Ixempra 51 approvable letter 51 TRANSDUR Bupivacaine 51 Meets Primary Endpoint 51 Liprotamase 51 Roche Actemra 51 Ustekinumab 51 Bifeprunox 51 Vion Pharmaceuticals 51 Drug Eluting Stent System 51 brentuximab 51 Celgene Thalomid 51 NitroMist 51 MT#/MEDI-# 51 non nucleoside HCV 51 COLAZAL R 51 Novartis AG Galvus 51 cethromycin NDA 51 novel histone deacetylase 51 Receives CE Marking 51 Loramyc 51 Addex Pharmaceuticals Ltd. 51 Receives Complete Response 51 KRN# 51 SCIB1 51 Backs FY# View 51 Ligand Pharmaceuticals Incorporated 51 SHP.L 51 Oglemilast 51 TSX PLB leading 51 Zactima 51 corticotropin injection 51 Zelrix 51 ANDA approvals 51 CRTX 51 IRX 2 51 Novel Antibiotic 51 FACTIVE tablets 51 Junovan 51 Rating = #.#/#.# 51 Inc. Nasdaq ATHX 51 Annamycin 51 Vitaros 51 Increlex TM 51 NASDAQ Listing Qualification 51 Premarket Approval 51 Targretin capsules 51 Investigational 51 ORTHOVISC mini 51 Initiates Phase II 51 Cellegesic 51 Spiegelmer ® 51 Brentuximab Vedotin SGN 51 CryoSeal FS System 51 Oporia 51 Nasdaq PCYC 51 LEUKINE 51 TSX PLI ProMetic 51 Frova ® 51 Rhucin ® recombinant 51 midstage clinical 51 Nasdaq MYL 51 Primera Bioscience 51 include Phenoptin TM 51 Lebowa transaction 51 motexafin gadolinium Injection 51 Generic Version 51 DASISION 51 Surfaxin LS 51 tramiprosate ALZHEMED TM 51 Gattex 51 Focetria 51 Inc. Nasdaq BCRX 51 read Palintologist 51 IV acetaminophen 51 subsidiary Glenmark Generics 51 Nasdaq Deficiency Notice 51 QNEXA ® 51 Indiplon 51 Vitrasert R 51 NASDAQ ALTU 51 LidoPAIN SP 51 confirmatory Phase 3 51 authority Gurian Sherman 51 Keppra ® XR 51 Nasdaq ADLR 51 publication StockRich.com 51 Fast Track designation 51 LE SN# 51 By Malcolm Maclachlan 51 Ceplene ® histamine dihydrochloride 51 PrevOnco 51 MK #B 51 OLEPTRO 51 NASDAQ Delisting Notice 51 Aganocide 51 OTCBB PYTO 51 Zyflo 51 Q#IR 51 Nasdaq IDRA today 51 Nasdaq FOLD 51 octreotide implant 51 Orphan Status 51 Receives Orphan Drug Designation 51 pulls Darvon painkiller 51 Welichem 51 Nasdaq ONXX today 51 Prodarsan 51 markets COLAZAL 51 e mail sports@baltsun.com 51 k premarket 51 Silenor ® doxepin 51 Phase IIb Trial 51 inhaled formulation 51 Davanat 51 FIRAZYR 51 HuMax TAC 51 NI #-# Preliminary Assessment 51 tafamidis 51 IIa clinical 51 rhLF 51 product platforms AZX# 51 RGIN 51 Amigal TM 51 Phase #/#a trial 51 Medicinal Products EMEA 51 MONOVISC 51 ONSOLIS 51 LEVADEX TM 51 By KushalSharma TennisEarth.com 51 Tranzyme Pharma 51 Icatibant 51 KIF6 Genotyping Assay 51 www.emagazine.com/earthtalk/thisweek/ 51 Ferumoxytol 51 FlexStent ® 51 Inc. Nasdaq NSTK 51 Pegloticase 51 IV APAP 51 Nasdaq CYCC 51 HEPLISAV ™ 51 Scivanta Medical Corporation 51 NASDAQ ARIA 51 vilazodone 51 Nasdaq AUXL 51 CureTech 51 NeoLipid drug 51 WILEX AG 51 Zytiga 51 Inc. Nasdaq PTIE 51 budiodarone 51 Protalix BioTherapeutics 51 SYCREST 51 Lauren Silvernail 51 Nasdaq IMGN 51 Keryx Biopharma 51 Orphan Therapeutics 51 NVA# 51 ALTROPANE R 51 vinflunine 51 Emezine R 51 IDEV Technologies 51 Inspire Pharma 51 IL# PE#QQR 50 collaborator Genentech 50 NASDAQ NOVN 50 Anchen Pharmaceuticals Inc. 50 commercialized DURECT 50 biogeneric 50 Dalbavancin 50 Phase 2b Clinical Trial 50 Gamunex C 50 REMOXY R 50 publication Hototc.com 50 Omigard TM 50 RBXLF 50 Phase IIa clinical trials 50 ofatumumab HuMax CD# 50 Restanza 50 PRNewswire FirstCall Sunesis Pharmaceuticals 50 Presents Positive 50 Manja Bouman CEO 50 seliciclib CYC# 50 PRNewswire FirstCall Palatin Technologies 50 Phase IIb Clinical Trial 50 Penwest Pharmaceuticals Co 50 ADVANCE PD 50 MARIFIL MINES LTD 50 EndoTAG TM -1 50 Retacrit 50 Alnara Pharmaceuticals 50 Nasdaq ACOR 50 Partnering Agreements 50 Applications ANDA 50 Ultracet R 50 Visian Toric ICL 50 TSX DMM Dynasty 50 Pruvel 50 By Doris Yon 50 dihydrochloride Tablets 50 By GokulPillai TennisEarth.com 50 TIMET Reports 50 David Gower P.Geo 50 nalbuphine ER 50 compound CIP FENOFIBRATE 50 EPIX Pharmaceuticals 50 SIX BSLN 50 Bioral Amphotericin B 50 Cutanea 50 ALN TTR 50 Tekturna HCT ® 50 NUEDEXTA ™ 50 PF # [002] 50 Veronate 50 Trubion Pharmaceuticals TRBN 50 NASDAQ CPEX 50 Fusilev 50 TSX VENTURE PEF 50 Investigational Oral 50 Vinnie Ciurciu LB 50 Stedesa 50 lucinactant 50 non nucleoside inhibitor 50 Linjeta ™ 50 Jerini 50 BEMA Granisetron 50 Ziopharm Oncology 50 exemption IDE 50 Deferiprone 50 Unifill syringe 50 Adamis Pharmaceuticals Corporation 50 Inc. Nasdaq VRUS 50 Addex Pharmaceuticals SWISS ADXN 50 Genentech Roche 50 novel bactericidal 50 Expression Genetics 50 Acthar repository corticotropin injection 50 Inc. NASDAQ ISPH 50 Xenazine ® 50 Ambrisentan 50 Shire BioChem Inc. 50 ADVEXIN p# therapy 50 PRNewswire FirstCall Pharmasset 50 aerosolized AAT 50 Ceplene TM 50 Chretiens ordeal 50 Jeffrey Leebaw spokesman 50 Biopartners 50 Kiacta 50 Sunesis Pharma 50 omacetaxine mepesuccinate 50 Praecis 50 Alvesco R 50 FDA Endocrinologic 50 bicifadine 50 Promacta 50 NYSE MYL 50 cutaneous T 50 Phase Ib clinical trials 50 #k PMA sNDA 50 NASDAQ CGPI today 50 Tasigna nilotinib 50 Ercole Biotech 50 Initiates Clinical 50 Ruconest 50 Nasdaq ICOS 50 Inc. NASDAQ AGIX 50 Cobalt Pharmaceuticals 50 Tesmilifene 50 ACCLAIM II 50 Andrea Cornell Sarvady 50 Eurand NV EURX 50 Aegerion 50 Amgen Prolia 50 generation purine nucleoside 50 ATryn R 50 depressive episodes associated 50 Renvela 50 Velac 50 Inc. Nasdaq VVUS 50 Pivotal Trial 50 Dynepo TM 50 Loramyc R 50 R galsulfase 50 Zensana TM 50 Galida 50 entity NCE 50 Afrezza 50 Aurexis 50 Vimpat R 50 Fibrocell Science Inc. 50 Naproxcinod 50 Phase IIb clinical trials 50 AVERROES 50 Shigamabs ® 50 Completes Patient Enrolment 50 Pfizer inhaled insulin 50 IMPDH inhibitor 50 SILENOR ™ 50 Generic Protonix 50 suburban St.Louis 50 ingredients decongestants expectorants 50 Anti Infective Drugs 50 Pirespa 50 gave Makena orphan 50 InSight Publisher 50 histamine dihydrochloride 50 Ascend Therapeutics 50 Mr. Bob Komarechka 50 Ambulatory EHR certification 50 Perflubutane Polymer Microspheres 50 Ophthalmic Drugs Advisory 50 bardoxolone 50 Oxytrex TM 50 TOCOSOL Camptothecin 50 Naglazyme R 50 EPCT 50 FDA 50 By AjayTyagi TennisEarth.com 50 Par Pharmaceuticals 50 ASX UNS today 50 Edu marking Tanaguchi 50 Zemiva TM 50 OROS R Hydromorphone 50 generic Allegra 50 Orphan Drug Status 50 Biophan patent 50 Meritage Pharma 50 Valeant Pharma 50 GSK# [002] 50 Nasdaq SLXP 50 zolpidem tartrate sublingual tablet 50 VISICOL R 50 Lymphoseek ® 50 APTIMA HPV assay 50 Spokesman Josef Blumenfeld 50 Accentia Biopharmaceuticals 50 Belimumab 50 European Marketing Authorizations 50 Alvesco 50 DIFICID ™ 50 miconazole Lauriad R 50 Revises FY# Outlook 50 Phase #/#a 50 CUSF application 50 By RAYMOND PEFFERMAN 50 Affymax AFFY 50 Onrigin 50 generic Norvasc